,date,title,url
0,2003-04-24,联环药业第一季度季报,/disclosure/listedinfo/announcement/c/2003-04-24/600513_2003_1.pdf
1,2003-08-28,联环药业半年报,/disclosure/listedinfo/announcement/c/2003-08-28/600513_2003_z.pdf
2,2003-10-28,联环药业第三季度季报,/disclosure/listedinfo/announcement/c/2003-10-28/600513_2003_3.pdf
3,2004-04-22,联环药业投资者关系管理制度,/disclosure/listedinfo/announcement/c/2004-04-22/600513_20040422_9.pdf
4,2004-04-22,联环药业年报,/disclosure/listedinfo/announcement/c/2004-04-22/600513_2003_n.pdf
5,2004-04-22,联环药业募集资金管理制度,/disclosure/listedinfo/announcement/c/2004-04-22/600513_20040422_4.pdf
6,2004-04-22,联环药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-22/600513_20040422_2.pdf
7,2004-04-22,联环药业改变募集资金用途公告,/disclosure/listedinfo/announcement/c/2004-04-22/600513_20040422_3.pdf
8,2004-04-22,联环药业董事会战略委员会工作细则,/disclosure/listedinfo/announcement/c/2004-04-22/600513_20040422_5.pdf
9,2004-04-22,联环药业董事会薪酬与考核委员会工作细则,/disclosure/listedinfo/announcement/c/2004-04-22/600513_20040422_6.pdf
10,2004-04-22,联环药业董事会提名委员会工作细则,/disclosure/listedinfo/announcement/c/2004-04-22/600513_20040422_8.pdf
11,2004-04-22,联环药业董事会审计委员会工作细则,/disclosure/listedinfo/announcement/c/2004-04-22/600513_20040422_7.pdf
12,2004-04-22,联环药业董事会决议公告暨召开2003年度股东大会通知,/disclosure/listedinfo/announcement/c/2004-04-22/600513_20040422_1.pdf
13,2004-04-22,联环药业第一季度季报,/disclosure/listedinfo/announcement/c/2004-04-22/600513_2004_1.pdf
14,2004-05-14,联环药业回访报告,/disclosure/listedinfo/announcement/c/2004-05-14/600513_20040514_1.pdf
15,2004-05-25,联环药业上市公司章程,/disclosure/listedinfo/announcement/c/2004-05-25/600513_20040525_g.pdf
16,2004-05-25,联环药业2003年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-05-25/600513_20040525_1.pdf
17,2004-06-28,联环药业分红派息实施公告,/disclosure/listedinfo/announcement/c/2004-06-28/600513_20040628_1.pdf
18,2004-08-06,联环药业半年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2004-08-06/600513_2004_zzy.pdf
19,2004-08-06,联环药业半年报,/disclosure/listedinfo/announcement/c/2004-08-06/600513_2004_z.pdf
20,2004-08-11,联环药业2004年半年度报告摘要更正公告,/disclosure/listedinfo/announcement/c/2004-08-11/600513_20040811_1.pdf
21,2004-10-28,联环药业第三季度季报,/disclosure/listedinfo/announcement/c/2004-10-28/600513_2004_3.pdf
22,2005-04-22,联环药业上市公司章程,/disclosure/listedinfo/announcement/c/2005-04-22/600513_20050422_g.pdf
23,2005-04-22,联环药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2005-04-22/600513_20050422_3.pdf
24,2005-04-22,联环药业年报摘要,/disclosure/listedinfo/announcement/c/2005-04-22/600513_2004_nzy.pdf
25,2005-04-22,联环药业年报(修订版),/disclosure/listedinfo/announcement/c/2005-04-22/600513_2004_n.pdf
26,2005-04-22,联环药业监事会议事规则,/disclosure/listedinfo/announcement/c/2005-04-22/600513_20050422_6.pdf
27,2005-04-22,联环药业监事会决议公告,/disclosure/listedinfo/announcement/c/2005-04-22/600513_20050422_2.pdf
28,2005-04-22,联环药业独立董事工作制度,/disclosure/listedinfo/announcement/c/2005-04-22/600513_20050422_5.pdf
29,2005-04-22,联环药业董事会议事规则,/disclosure/listedinfo/announcement/c/2005-04-22/600513_20050422_4.pdf
30,2005-04-22,联环药业董事会决议暨关于召开2004年度股东大会通知的公告,/disclosure/listedinfo/announcement/c/2005-04-22/600513_20050422_1.pdf
31,2005-04-22,联环药业第一季度季报（修订版）,/disclosure/listedinfo/announcement/c/2005-04-22/600513_2005_1.pdf
32,2005-04-26,联环药业2005年一季度报告更正公告,/disclosure/listedinfo/announcement/c/2005-04-26/600513_20050426_1.pdf
33,2005-05-10,联环药业2004年年度报告补充公告,/disclosure/listedinfo/announcement/c/2005-05-10/600513_20050510_1.pdf
34,2005-05-24,联环药业2004年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-05-24/600513_20050524_1.pdf
35,2005-05-24,联环药业2004年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-05-24/600513_20050524_2.pdf
36,2005-07-08,联环药业分红派息实施公告,/disclosure/listedinfo/announcement/c/2005-07-08/600513_20050708_1.pdf
37,2005-08-08,联环药业半年报摘要,/disclosure/listedinfo/announcement/c/2005-08-08/600513_2005_zzy.pdf
38,2005-08-08,联环药业半年报,/disclosure/listedinfo/announcement/c/2005-08-08/600513_2005_z.pdf
39,2005-08-15,联环药业2005年半年度报告补充公告,/disclosure/listedinfo/announcement/c/2005-08-15/600513_20050815_1.pdf
40,2005-10-28,联环药业第三季度季报,/disclosure/listedinfo/announcement/c/2005-10-28/600513_2005_3.pdf
41,2006-02-13,联环药业关于召开A股市场相关股东会议的通知,/disclosure/listedinfo/announcement/c/2006-02-13/600513_20060213_1.pdf
42,2006-02-13,联环药业股权分置改革之法律意见书,/disclosure/listedinfo/announcement/c/2006-02-13/600513_20060213_5.pdf
43,2006-02-13,联环药业股权分置改革之保荐意见书,/disclosure/listedinfo/announcement/c/2006-02-13/600513_20060213_4.pdf
44,2006-02-13,联环药业股权分置改革说明书（摘要）,/disclosure/listedinfo/announcement/c/2006-02-13/600513_20060213_3.pdf
45,2006-02-13,联环药业股权分置改革说明书,/disclosure/listedinfo/announcement/c/2006-02-13/600513_20060213_2.pdf
46,2006-02-13,联环药业独立董事关于股权分置改革之独立意见,/disclosure/listedinfo/announcement/c/2006-02-13/600513_20060213_6.pdf
47,2006-02-13,联环药业董事会投票委托征集函,/disclosure/listedinfo/announcement/c/2006-02-13/600513_20060213_7.pdf
48,2006-02-14,联环药业股权分置改革征求意见函,/disclosure/listedinfo/announcement/c/2006-02-14/600513_20060214_2.pdf
49,2006-02-14,联环药业股权分置改革投资者网上沟通会公告,/disclosure/listedinfo/announcement/c/2006-02-14/600513_20060214_1.pdf
50,2006-02-22,联环药业关于股权分置改革方案沟通协商情况暨调整股权分置改革方案的公告,/disclosure/listedinfo/announcement/c/2006-02-22/600513_20060222_1.pdf
51,2006-02-22,联环药业股权分置改革之补充法律意见书,/disclosure/listedinfo/announcement/c/2006-02-22/600513_20060222_5.pdf
52,2006-02-22,联环药业股权分置改革之补充保荐意见书,/disclosure/listedinfo/announcement/c/2006-02-22/600513_20060222_4.pdf
53,2006-02-22,联环药业股权分置改革说明书摘要（修订稿）,/disclosure/listedinfo/announcement/c/2006-02-22/600513_20060222_3.pdf
54,2006-02-22,联环药业股权分置改革说明书（修订稿）,/disclosure/listedinfo/announcement/c/2006-02-22/600513_20060222_2.pdf
55,2006-02-22,联环药业独立董事关于调整股权分置改革方案的独立意见,/disclosure/listedinfo/announcement/c/2006-02-22/600513_20060222_6.pdf
56,2006-02-23,联环药业关于召开相关股东会议的第一次催告通知,/disclosure/listedinfo/announcement/c/2006-02-23/600513_20060223_1.pdf
57,2006-03-06,联环药业关于召开相关股东会议的第二次催告通知,/disclosure/listedinfo/announcement/c/2006-03-06/600513_20060306_1.pdf
58,2006-03-06,联环药业关于股权分置改革方案获得江苏省国资委批准的公告,/disclosure/listedinfo/announcement/c/2006-03-06/600513_20060306_2.pdf
59,2006-03-13,联环药业股权分置改革事项相关股东会议表决结果公告,/disclosure/listedinfo/announcement/c/2006-03-13/600513_20060313_1.pdf
60,2006-03-13,联环药业股权分置改革A股市场相关股东会议之法律意见书,/disclosure/listedinfo/announcement/c/2006-03-13/600513_20060313_2.pdf
61,2006-03-16,联环药业股权分置改革方案实施公告,/disclosure/listedinfo/announcement/c/2006-03-16/600513_20060316_1.pdf
62,2006-04-20,G联环与关联方资金往来及对外担保等情况的专项说明,/disclosure/listedinfo/announcement/c/2006-04-20/600513_20060420_4.pdf
63,2006-04-20,G联环年报摘要,/disclosure/listedinfo/announcement/c/2006-04-20/600513_2005_nzy.pdf
64,2006-04-20,G联环年报,/disclosure/listedinfo/announcement/c/2006-04-20/600513_2005_n.pdf
65,2006-04-20,G联环监事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-20/600513_20060420_2.pdf
66,2006-04-20,G联环董事会决议暨关于召开2005年度股东大会通知的公告,/disclosure/listedinfo/announcement/c/2006-04-20/600513_20060420_1.pdf
67,2006-04-20,G联环第一季度季报（修订版）,/disclosure/listedinfo/announcement/c/2006-04-20/600513_2006_1.pdf
68,2006-04-20,G联环2005年度日常关联交易公告,/disclosure/listedinfo/announcement/c/2006-04-20/600513_20060420_3.pdf
69,2006-05-10,G联环关于召开2005年度股东大会的补充通知公告,/disclosure/listedinfo/announcement/c/2006-05-10/600513_20060510_1.pdf
70,2006-05-11,G联环2006年第一季度报告补充公告,/disclosure/listedinfo/announcement/c/2006-05-11/600513_20060511_1.pdf
71,2006-05-23,G联环监事会决议公告,/disclosure/listedinfo/announcement/c/2006-05-23/600513_20060523_2.pdf
72,2006-05-23,G联环2005年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2006-05-23/600513_20060523_3.pdf
73,2006-05-23,G联环2005年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-05-23/600513_20060523_1.pdf
74,2006-07-11,G联环2005年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2006-07-11/600513_20060711_1.pdf
75,2006-08-22,G联环董事会决议公告,/disclosure/listedinfo/announcement/c/2006-08-22/600513_20060822_1.pdf
76,2006-08-22,G联环半年报摘要,/disclosure/listedinfo/announcement/c/2006-08-22/600513_2006_zzy.pdf
77,2006-08-22,G联环半年报,/disclosure/listedinfo/announcement/c/2006-08-22/600513_2006_z.pdf
78,2006-10-26,联环药业第三季度季报,/disclosure/listedinfo/announcement/c/2006-10-26/600513_2006_3.pdf
79,2007-03-30,联环药业有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2007-03-30/600513_20070330_1.pdf
80,2007-04-26,联环药业年报摘要,/disclosure/listedinfo/announcement/c/2007-04-26/600513_2006_nzy.pdf
81,2007-04-26,联环药业年报,/disclosure/listedinfo/announcement/c/2007-04-26/600513_2006_n.pdf
82,2007-04-26,联环药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-26/600513_20070426_2.pdf
83,2007-04-26,联环药业董事会决议暨关于召开公司2006年度股东大会通知的公告,/disclosure/listedinfo/announcement/c/2007-04-26/600513_20070426_1.pdf
84,2007-04-26,联环药业第一季度季报,/disclosure/listedinfo/announcement/c/2007-04-26/600513_2007_1.pdf
85,2007-04-26,联环药业2006年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2007-04-26/600513_20070426_3.pdf
86,2007-04-28,联环药业有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2007-04-28/600513_20070428_1.pdf
87,2007-05-17,联环药业关于出售资产的提示性公告,/disclosure/listedinfo/announcement/c/2007-05-17/600513_20070517_1.pdf
88,2007-05-19,联环药业股东减持股份公告,/disclosure/listedinfo/announcement/c/2007-05-19/600513_20070519_1.pdf
89,2007-05-29,联环药业职工代表大会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-05-29/600513_20070529_3.pdf
90,2007-05-29,联环药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-05-29/600513_20070529_2.pdf
91,2007-05-29,联环药业2006年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2007-05-29/600513_20070529_4.pdf
92,2007-05-29,联环药业2006年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-05-29/600513_20070529_1.pdf
93,2007-06-02,联环药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2007-06-02/600513_20070602_1.pdf
94,2007-07-10,联环药业股东减持股份公告,/disclosure/listedinfo/announcement/c/2007-07-10/600513_20070710_1.pdf
95,2007-07-17,联环药业2006年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2007-07-17/600513_20070717_1.pdf
96,2007-08-22,联环药业子公司管理控制制度,/disclosure/listedinfo/announcement/c/2007-08-22/600513_20070822_4.pdf
97,2007-08-22,联环药业信息披露事务管理制度,/disclosure/listedinfo/announcement/c/2007-08-22/600513_20070822_5.pdf
98,2007-08-22,联环药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-08-22/600513_20070822_2.pdf
99,2007-08-22,联环药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-08-22/600513_20070822_1.pdf
100,2007-08-22,联环药业半年报摘要,/disclosure/listedinfo/announcement/c/2007-08-22/600513_2007_zzy.pdf
101,2007-08-22,联环药业半年报,/disclosure/listedinfo/announcement/c/2007-08-22/600513_2007_z.pdf
102,2007-08-22,联环药业“公司治理专项活动”自查报告和整改计划,/disclosure/listedinfo/announcement/c/2007-08-22/600513_20070822_3.pdf
103,2007-09-27,联环药业股东减持股份公告,/disclosure/listedinfo/announcement/c/2007-09-27/600513_20070927_1.pdf
104,2007-10-26,联环药业有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2007-10-26/600513_20071026_3.pdf
105,2007-10-26,联环药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-10-26/600513_20071026_2.pdf
106,2007-10-26,联环药业董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2007-10-26/600513_20071026_1.pdf
107,2007-10-26,联环药业第三季度季报,/disclosure/listedinfo/announcement/c/2007-10-26/600513_2007_3.pdf
108,2007-11-13,联环药业关于加强上市公司治理专项活动的整改报告,/disclosure/listedinfo/announcement/c/2007-11-13/600513_20071113_2.pdf
109,2007-11-13,联环药业董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-11-13/600513_20071113_1.pdf
110,2007-11-20,联环药业2007年第一次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2007-11-20/600513_20071120_2.pdf
111,2007-11-20,联环药业2007年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-11-20/600513_20071120_1.pdf
112,2007-12-04,联环药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-12-04/600513_20071204_3.pdf
113,2007-12-04,联环药业改变募集资金用途暨关联交易公告,/disclosure/listedinfo/announcement/c/2007-12-04/600513_20071204_2.pdf
114,2007-12-04,联环药业董事会临时会议决议公告暨关于召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2007-12-04/600513_20071204_1.pdf
115,2007-12-20,联环药业2007年第二次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2007-12-20/600513_20071220_2.pdf
116,2007-12-20,联环药业2007年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-12-20/600513_20071220_1.pdf
117,2008-01-04,联环药业股东减持股份公告,/disclosure/listedinfo/announcement/c/2008-01-04/600513_20080104_1.pdf
118,2008-04-18,联环药业年报摘要,/disclosure/listedinfo/announcement/c/2008-04-18/600513_2007_nzy.pdf
119,2008-04-18,联环药业年报,/disclosure/listedinfo/announcement/c/2008-04-18/600513_2007_n.pdf
120,2008-04-18,联环药业监事会决议公告,/disclosure/listedinfo/announcement/c/2008-04-18/600513_20080418_2.pdf
121,2008-04-18,联环药业独立董事年报工作制度,/disclosure/listedinfo/announcement/c/2008-04-18/600513_20080418_4.pdf
122,2008-04-18,联环药业董事会审计委员会年度财务报告审计工作规程,/disclosure/listedinfo/announcement/c/2008-04-18/600513_20080418_5.pdf
123,2008-04-18,联环药业董事会决议公告暨关于召开公司2007年度股东大会的通知,/disclosure/listedinfo/announcement/c/2008-04-18/600513_20080418_1.pdf
124,2008-04-18,联环药业第一季度季报,/disclosure/listedinfo/announcement/c/2008-04-18/600513_2008_1.pdf
125,2008-04-18,联环药业2007年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2008-04-18/600513_20080418_3.pdf
126,2008-05-09,联环药业2007年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2008-05-09/600513_20080509_2.pdf
127,2008-05-09,联环药业2007年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-05-09/600513_20080509_1.pdf
128,2008-05-26,联环药业分配及转增股本实施公告,/disclosure/listedinfo/announcement/c/2008-05-26/600513_20080526_1.pdf
129,2008-07-31,联环药业关于公司治理整改事项整改情况的说明,/disclosure/listedinfo/announcement/c/2008-07-31/600513_20080731_2.pdf
130,2008-07-31,联环药业第三届董事会第四次临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-07-31/600513_20080731_1.pdf
131,2008-08-20,联环药业内部审计制度,/disclosure/listedinfo/announcement/c/2008-08-20/600513_20080820_2.pdf
132,2008-08-20,联环药业第三届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2008-08-20/600513_20080820_1.pdf
133,2008-08-20,联环药业半年报摘要,/disclosure/listedinfo/announcement/c/2008-08-20/600513_2008_zzy.pdf
134,2008-08-20,联环药业半年报,/disclosure/listedinfo/announcement/c/2008-08-20/600513_2008_z.pdf
135,2008-08-22,联环药业半年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2008-08-22/600513_2008_zzy.pdf
136,2008-08-22,联环药业半年报（修订版）,/disclosure/listedinfo/announcement/c/2008-08-22/600513_2008_z.pdf
137,2008-08-22,联环药业2008年半年度报告更正公告,/disclosure/listedinfo/announcement/c/2008-08-22/600513_20080822_1.pdf
138,2008-09-27,联环药业关于公司大股东所持部分本公司股份被解除诉前保全的公告,/disclosure/listedinfo/announcement/c/2008-09-27/600513_20080927_1.pdf
139,2008-10-22,联环药业第三季度季报,/disclosure/listedinfo/announcement/c/2008-10-22/600513_2008_3.pdf
140,2008-10-30,联环药业关于本公司大股东更名、增资的公告,/disclosure/listedinfo/announcement/c/2008-10-30/600513_20081030_1.pdf
141,2008-11-19,联环药业敏感信息归集、保密及披露制度,/disclosure/listedinfo/announcement/c/2008-11-19/600513_20081119_2.pdf
142,2008-11-19,联环药业第三届董事会第五次临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-11-19/600513_20081119_1.pdf
143,2009-01-21,联环药业关于本公司被认定为高新技术企业的公告,/disclosure/listedinfo/announcement/c/2009-01-21/600513_20090121_1.pdf
144,2009-02-04,联环药业股东减持股份公告,/disclosure/listedinfo/announcement/c/2009-02-04/600513_20090204_1.pdf
145,2009-02-11,联环药业关于更换股改保荐代表人的公告,/disclosure/listedinfo/announcement/c/2009-02-11/600513_20090211_1.pdf
146,2009-03-19,联环药业有限售条件的流通股上市流通的公告,/disclosure/listedinfo/announcement/c/2009-03-19/600513_20090319_1.pdf
147,2009-04-22,联环药业年报摘要,/disclosure/listedinfo/announcement/c/2009-04-22/600513_2008_nzy.pdf
148,2009-04-22,联环药业年报,/disclosure/listedinfo/announcement/c/2009-04-22/600513_2008_n.pdf
149,2009-04-22,联环药业关于召开公司2008年度股东大会的通知,/disclosure/listedinfo/announcement/c/2009-04-22/600513_20090422_2.pdf
150,2009-04-22,联环药业董事会审计委员会年报工作规程,/disclosure/listedinfo/announcement/c/2009-04-22/600513_20090422_5.pdf
151,2009-04-22,联环药业第一季度季报,/disclosure/listedinfo/announcement/c/2009-04-22/600513_2009_1.pdf
152,2009-04-22,联环药业第三届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2009-04-22/600513_20090422_3.pdf
153,2009-04-22,联环药业第三届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2009-04-22/600513_20090422_1.pdf
154,2009-04-22,联环药业2008年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2009-04-22/600513_20090422_4.pdf
155,2009-04-23,联环药业第一季度季报（修订版）,/disclosure/listedinfo/announcement/c/2009-04-23/600513_2009_1.pdf
156,2009-04-23,联环药业2009年第一季度报告补充公告,/disclosure/listedinfo/announcement/c/2009-04-23/600513_20090423_1.pdf
157,2009-04-30,联环药业股票异常波动公告,/disclosure/listedinfo/announcement/c/2009-04-30/600513_20090430_1.pdf
158,2009-05-23,联环药业职工代表大会临时会议决议公告,/disclosure/listedinfo/announcement/c/2009-05-23/600513_20090523_1.pdf
159,2009-05-23,联环药业2008年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2009-05-23/600513_20090523_3.pdf
160,2009-05-23,联环药业2008年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-05-23/600513_20090523_2.pdf
161,2009-06-20,联环药业第四届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2009-06-20/600513_20090620_3.pdf
162,2009-06-20,联环药业第四届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2009-06-20/600513_20090620_2.pdf
163,2009-07-08,联环药业2008年利润分配实施公告,/disclosure/listedinfo/announcement/c/2009-07-08/600513_20090708_1.pdf
164,2009-08-20,联环药业防范大股东及关联方占用上市公司资金管理制度,/disclosure/listedinfo/announcement/c/2009-08-20/600513_20090820_2.pdf
165,2009-08-20,联环药业第四届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2009-08-20/600513_20090820_1.pdf
166,2009-08-20,联环药业半年报摘要,/disclosure/listedinfo/announcement/c/2009-08-20/600513_2009_zzy.pdf
167,2009-08-20,联环药业半年报,/disclosure/listedinfo/announcement/c/2009-08-20/600513_2009_z.pdf
168,2009-10-20,联环药业关于本公司董事王海敏女士辞职的公告,/disclosure/listedinfo/announcement/c/2009-10-20/600513_20091020_1.pdf
169,2009-10-28,联环药业第三季度季报,/disclosure/listedinfo/announcement/c/2009-10-28/600513_2009_3.pdf
170,2009-11-03,联环药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2009-11-03/600513_20091103_1.pdf
171,2010-03-11,联环药业关于本公司独立董事刁九国先生辞职的公告,/disclosure/listedinfo/announcement/c/2010-03-11/600513_20100311_1.pdf
172,2010-04-17,联环药业总经理工作细则,/disclosure/listedinfo/announcement/c/2010-04-17/600513_20100417_5.pdf
173,2010-04-17,联环药业专业推广队伍绩效管理实施细则,/disclosure/listedinfo/announcement/c/2010-04-17/600513_20100417_13.pdf
174,2010-04-17,联环药业专业推广队伍2010年奖励政策,/disclosure/listedinfo/announcement/c/2010-04-17/600513_20100417_14.pdf
175,2010-04-17,联环药业专业推广队伍2010年度行政费用管理制度,/disclosure/listedinfo/announcement/c/2010-04-17/600513_20100417_15.pdf
176,2010-04-17,联环药业外部信息使用人管理制度,/disclosure/listedinfo/announcement/c/2010-04-17/600513_20100417_6.pdf
177,2010-04-17,联环药业年报摘要,/disclosure/listedinfo/announcement/c/2010-04-17/600513_2009_nzy.pdf
178,2010-04-17,联环药业年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2010-04-17/600513_20100417_7.pdf
179,2010-04-17,联环药业年报,/disclosure/listedinfo/announcement/c/2010-04-17/600513_2009_n.pdf
180,2010-04-17,联环药业内幕信息知情人登记管理制度,/disclosure/listedinfo/announcement/c/2010-04-17/600513_20100417_8.pdf
181,2010-04-17,联环药业内部控制监督检查制度,/disclosure/listedinfo/announcement/c/2010-04-17/600513_20100417_9.pdf
182,2010-04-17,联环药业关于召开公司2009年度股东大会的通知,/disclosure/listedinfo/announcement/c/2010-04-17/600513_20100417_3.pdf
183,2010-04-17,联环药业关联交易管理制度,/disclosure/listedinfo/announcement/c/2010-04-17/600513_20100417_10.pdf
184,2010-04-17,联环药业董事会秘书工作细则,/disclosure/listedinfo/announcement/c/2010-04-17/600513_20100417_11.pdf
185,2010-04-17,联环药业董事、监事和高级管理人员持股及其变动管理制度,/disclosure/listedinfo/announcement/c/2010-04-17/600513_20100417_12.pdf
186,2010-04-17,联环药业第一季度季报,/disclosure/listedinfo/announcement/c/2010-04-17/600513_2010_1.pdf
187,2010-04-17,联环药业第四届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-17/600513_20100417_2.pdf
188,2010-04-17,联环药业第四届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-17/600513_20100417_1.pdf
189,2010-04-17,联环药业2009年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2010-04-17/600513_20100417_4.pdf
190,2010-05-11,联环药业股东大会累积投票制实施细则,/disclosure/listedinfo/announcement/c/2010-05-11/600513_20100511_3.pdf
191,2010-05-11,联环药业2009年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2010-05-11/600513_20100511_2.pdf
192,2010-05-11,联环药业2009年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-05-11/600513_20100511_1.pdf
193,2010-05-31,联环药业2009年度利润分配及公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2010-05-31/600513_20100531_1.pdf
194,2010-06-01,联环药业更正公告,/disclosure/listedinfo/announcement/c/2010-06-01/600513_20100601_1.pdf
195,2010-08-03,联环药业第四届董事会第一次临时会议决议公告,/disclosure/listedinfo/announcement/c/2010-08-03/600513_20100803_1.pdf
196,2010-08-17,联环药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2010-08-17/600513_20100817_1.pdf
197,2010-08-19,联环药业澄清公告,/disclosure/listedinfo/announcement/c/2010-08-19/600513_20100819_1.pdf
198,2010-08-20,联环药业第四届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2010-08-20/600513_20100820_1.pdf
199,2010-08-20,联环药业半年报摘要,/disclosure/listedinfo/announcement/c/2010-08-20/600513_2010_zzy.pdf
200,2010-08-20,联环药业半年报,/disclosure/listedinfo/announcement/c/2010-08-20/600513_2010_z.pdf
201,2010-08-21,联环药业内部控制监督检查制度,/disclosure/listedinfo/announcement/c/2010-08-21/600513_20100821_1.pdf
202,2010-08-21,联环药业半年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2010-08-21/600513_2010_zzy.pdf
203,2010-08-21,联环药业半年报（修订版）,/disclosure/listedinfo/announcement/c/2010-08-21/600513_2010_z.pdf
204,2010-08-24,联环药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2010-08-24/600513_20100824_1.pdf
205,2010-09-03,联环药业关于公司大股东减持本公司股票的公告,/disclosure/listedinfo/announcement/c/2010-09-03/600513_20100903_1.pdf
206,2010-09-03,联环药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2010-09-03/600513_20100903_2.pdf
207,2010-10-28,联环药业第三季度季报,/disclosure/listedinfo/announcement/c/2010-10-28/600513_2010_3.pdf
208,2011-04-22,联环药业年报摘要,/disclosure/listedinfo/announcement/c/2011-04-22/600513_2010_nzy.pdf
209,2011-04-22,联环药业年报,/disclosure/listedinfo/announcement/c/2011-04-22/600513_2010_n.pdf
210,2011-04-22,联环药业关于召开公司2010年度股东大会的通知,/disclosure/listedinfo/announcement/c/2011-04-22/600513_20110422_3.pdf
211,2011-04-22,联环药业关于本公司独立董事葛军先生辞职的公告,/disclosure/listedinfo/announcement/c/2011-04-22/600513_20110422_4.pdf
212,2011-04-22,联环药业第一季度季报,/disclosure/listedinfo/announcement/c/2011-04-22/600513_2011_1.pdf
213,2011-04-22,联环药业第四届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-22/600513_20110422_2.pdf
214,2011-04-22,联环药业第四届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-22/600513_20110422_1.pdf
215,2011-04-22,联环药业2010年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2011-04-22/600513_20110422_5.pdf
216,2011-05-11,联环药业董事会秘书工作制度,/disclosure/listedinfo/announcement/c/2011-05-11/600513_20110511_1.pdf
217,2011-05-17,联环药业公司章程（2011修订),/disclosure/listedinfo/announcement/c/2011-05-17/600513_20110517_g.pdf
218,2011-05-17,联环药业2010年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2011-05-17/600513_20110517_2.pdf
219,2011-05-17,联环药业2010年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-05-17/600513_20110517_1.pdf
220,2011-06-14,联环药业2010年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2011-06-14/600513_20110614_1.pdf
221,2011-08-20,联环药业半年报摘要,/disclosure/listedinfo/announcement/c/2011-08-20/600513_2011_zzy.pdf
222,2011-08-20,联环药业半年报,/disclosure/listedinfo/announcement/c/2011-08-20/600513_2011_z.pdf
223,2011-08-27,联环药业关于江苏金茂化工医药集团有限公司公开转让江苏联环药业集团有限公司部分股权的公告,/disclosure/listedinfo/announcement/c/2011-08-27/600513_20110827_1.pdf
224,2011-10-26,联环药业第三季度季报,/disclosure/listedinfo/announcement/c/2011-10-26/600513_2011_3.pdf
225,2011-12-13,联环药业关于重大资产收购的提示性公告,/disclosure/listedinfo/announcement/c/2011-12-13/600513_20111213_1.pdf
226,2011-12-21,联环药业第四届董事会第四次临时会议决议公告,/disclosure/listedinfo/announcement/c/2011-12-21/600513_20111221_1.pdf
227,2011-12-24,联环药业关于公司2011年度审计机构名称变更的公告,/disclosure/listedinfo/announcement/c/2011-12-24/600513_20111224_1.pdf
228,2011-12-27,联环药业内幕信息知情人登记管理制度,/disclosure/listedinfo/announcement/c/2011-12-27/600513_20111227_2.pdf
229,2011-12-27,联环药业第四届董事会第五次临时会议决议公告,/disclosure/listedinfo/announcement/c/2011-12-27/600513_20111227_1.pdf
230,2012-01-12,联环药业提示性公告,/disclosure/listedinfo/announcement/c/2012-01-12/600513_20120112_1.pdf
231,2012-03-28,联环药业实施内部控制规范工作方案,/disclosure/listedinfo/announcement/c/2012-03-28/600513_20120328_2.pdf
232,2012-03-28,联环药业第四届董事会第六次临时会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-28/600513_20120328_1.pdf
233,2012-04-20,联环药业年报摘要,/disclosure/listedinfo/announcement/c/2012-04-20/600513_2011_nzy.pdf
234,2012-04-20,联环药业年报,/disclosure/listedinfo/announcement/c/2012-04-20/600513_2011_n.pdf
235,2012-04-20,联环药业关于召开公司2011年度股东大会的通知,/disclosure/listedinfo/announcement/c/2012-04-20/600513_20120420_2.pdf
236,2012-04-20,联环药业独立董事2011年度述职报告,/disclosure/listedinfo/announcement/c/2012-04-20/600513_20120420_6.pdf
237,2012-04-20,联环药业第一季度季报,/disclosure/listedinfo/announcement/c/2012-04-20/600513_2012_1.pdf
238,2012-04-20,联环药业第四届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2012-04-20/600513_20120420_3.pdf
239,2012-04-20,联环药业第四届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2012-04-20/600513_20120420_1.pdf
240,2012-04-20,联环药业2011年度日常关联交易公告,/disclosure/listedinfo/announcement/c/2012-04-20/600513_20120420_4.pdf
241,2012-04-20,联环药业2011年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2012-04-20/600513_20120420_5.pdf
242,2012-05-03,联环药业关于江苏联环药业集团有限公司部分国有股权公开转让进展情况的公告,/disclosure/listedinfo/announcement/c/2012-05-03/600513_20120503_1.pdf
243,2012-05-15,联环药业职工代表大会临时会议决议公告,/disclosure/listedinfo/announcement/c/2012-05-15/600513_20120515_2.pdf
244,2012-05-15,联环药业2011年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2012-05-15/600513_20120515_3.pdf
245,2012-05-15,联环药业2011年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-05-15/600513_20120515_1.pdf
246,2012-05-22,联环药业第五届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2012-05-22/600513_20120522_2.pdf
247,2012-05-22,联环药业第五届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2012-05-22/600513_20120522_1.pdf
248,2012-06-21,联环药业2011年度利润分配和转增股本实施公告,/disclosure/listedinfo/announcement/c/2012-06-21/600513_20120621_1.pdf
249,2012-08-06,联环药业重大资产重组事项停牌公告,/disclosure/listedinfo/announcement/c/2012-08-06/600513_20120806_2.pdf
250,2012-08-06,联环药业关于江苏联环药业集团有限公司部分国有股权公开转让完成的公告,/disclosure/listedinfo/announcement/c/2012-08-06/600513_20120806_1.pdf
251,2012-08-13,联环药业重大资产重组事项进展公告,/disclosure/listedinfo/announcement/c/2012-08-13/600513_20120813_1.pdf
252,2012-08-20,联环药业重大资产重组事项进展公告,/disclosure/listedinfo/announcement/c/2012-08-20/600513_20120820_1.pdf
253,2012-08-22,联环药业第五届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2012-08-22/600513_20120822_1.pdf
254,2012-08-22,联环药业半年报摘要,/disclosure/listedinfo/announcement/c/2012-08-22/600513_2012_zzy.pdf
255,2012-08-22,联环药业半年报,/disclosure/listedinfo/announcement/c/2012-08-22/600513_2012_z.pdf
256,2012-08-27,联环药业重大资产重组事项进展公告,/disclosure/listedinfo/announcement/c/2012-08-27/600513_20120827_1.pdf
257,2012-09-03,联环药业重大资产重组延期复牌公告,/disclosure/listedinfo/announcement/c/2012-09-03/600513_20120903_1.pdf
258,2012-09-10,联环药业重大资产重组事项进展公告,/disclosure/listedinfo/announcement/c/2012-09-10/600513_20120910_1.pdf
259,2012-09-17,联环药业重大资产重组事项进展公告,/disclosure/listedinfo/announcement/c/2012-09-17/600513_20120917_1.pdf
260,2012-09-24,联环药业重大资产重组事项进展公告,/disclosure/listedinfo/announcement/c/2012-09-24/600513_20120924_1.pdf
261,2012-09-27,联环药业发行股份购买资产暨关联交易报告书摘要（草案）,/disclosure/listedinfo/announcement/c/2012-09-27/600513_20120927_2.pdf
262,2012-09-27,联环药业发行股份购买资产暨关联交易报告书（草案）,/disclosure/listedinfo/announcement/c/2012-09-27/600513_20120927_3.pdf
263,2012-09-27,联环药业第五届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2012-09-27/600513_20120927_1.pdf
264,2012-10-26,联环药业重大资产重组事项进展公告,/disclosure/listedinfo/announcement/c/2012-10-26/600513_20121026_1.pdf
265,2012-10-26,联环药业第三季度季报,/disclosure/listedinfo/announcement/c/2012-10-26/600513_2012_3.pdf
266,2012-11-27,联环药业重大资产重组事项进展公告,/disclosure/listedinfo/announcement/c/2012-11-27/600513_20121127_1.pdf
267,2012-12-27,联环药业重大资产重组事项进展公告,/disclosure/listedinfo/announcement/c/2012-12-26/600513_20121227_1.pdf
268,2013-01-05,联环药业综合服务协议,/disclosure/listedinfo/announcement/c/2013-01-04/600513_20130105_11.pdf
269,2013-01-05,联环药业资产收购涉及江苏联环药业集团有限公司持有扬州制药有限公司100%股权价值评估报告书,/disclosure/listedinfo/announcement/c/2013-01-04/600513_20130105_6.pdf
270,2013-01-05,联环药业与江苏联环药业集团有限公司发行股份购买资产协议之利润补偿协议,/disclosure/listedinfo/announcement/c/2013-01-04/600513_20130105_12.pdf
271,2013-01-05,联环药业与江苏联环药业集团有限公司发行股份购买资产协议之补充协议,/disclosure/listedinfo/announcement/c/2013-01-04/600513_20130105_13.pdf
272,2013-01-05,联环药业向特定对象发行股份购买资产暨关联交易的补充法律意见书,/disclosure/listedinfo/announcement/c/2013-01-04/600513_20130105_7.pdf
273,2013-01-05,联环药业关于召开公司2013年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-01-04/600513_20130105_2.pdf
274,2013-01-05,联环药业房屋租赁协议,/disclosure/listedinfo/announcement/c/2013-01-04/600513_20130105_10.pdf
275,2013-01-05,联环药业发行股份购买资产暨关联交易之独立财务顾问报告,/disclosure/listedinfo/announcement/c/2013-01-04/600513_20130105_5.pdf
276,2013-01-05,联环药业发行股份购买资产暨关联交易报告书摘要（草案）,/disclosure/listedinfo/announcement/c/2013-01-04/600513_20130105_4.pdf
277,2013-01-05,联环药业发行股份购买资产暨关联交易报告书（草案）,/disclosure/listedinfo/announcement/c/2013-01-04/600513_20130105_3.pdf
278,2013-01-05,联环药业独立董事关于《江苏联环药业股份有限公司资产收购涉及江苏联环药业集团有限公司持有扬州制药有限公司100%股权价值评估报告书》的独立意见,/disclosure/listedinfo/announcement/c/2013-01-04/600513_20130105_9.pdf
279,2013-01-05,联环药业第五届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2013-01-04/600513_20130105_1.pdf
280,2013-01-05,联环药业补充法律意见书签字页,/disclosure/listedinfo/announcement/c/2013-01-04/600513_20130105_8.pdf
281,2013-01-05,联环药业：扬州制药有限公司2012及2013年度盈利预测审核报告,/disclosure/listedinfo/announcement/c/2013-01-04/600513_20130105_15.pdf
282,2013-01-05,联环药业2012及2013年度备考盈利预测审核报告,/disclosure/listedinfo/announcement/c/2013-01-04/600513_20130105_14.pdf
283,2013-01-09,联环药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2013-01-08/600513_20130109_1.pdf
284,2013-01-09,联环药业更正公告,/disclosure/listedinfo/announcement/c/2013-01-08/600513_20130109_2.pdf
285,2013-01-16,联环药业关于召开公司2013年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2013-01-15/600513_20130116_1.pdf
286,2013-01-18,联环药业2013年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-01-17/600513_20130118_1.pdf
287,2013-01-23,联环药业2013年第一次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2013-01-22/600513_20130123_2.pdf
288,2013-01-23,联环药业2013年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-01-22/600513_20130123_1.pdf
289,2013-03-05,联环药业重大资产重组事项申请受理公告,/disclosure/listedinfo/announcement/c/2013-03-04/600513_20130305_1.pdf
290,2013-03-20,联环药业年报摘要,/disclosure/listedinfo/announcement/c/2013-03-19/600513_2012_nzy.pdf
291,2013-03-20,联环药业年报,/disclosure/listedinfo/announcement/c/2013-03-19/600513_2012_n.pdf
292,2013-03-20,联环药业独立董事对公司报告期内对外担保情况的专项说明和独立意见,/disclosure/listedinfo/announcement/c/2013-03-19/600513_20130320_5.pdf
293,2013-03-20,联环药业独立董事2012年度述职报告,/disclosure/listedinfo/announcement/c/2013-03-19/600513_20130320_7.pdf
294,2013-03-20,联环药业第五届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-19/600513_20130320_2.pdf
295,2013-03-20,联环药业第五届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-19/600513_20130320_1.pdf
296,2013-03-20,联环药业2012年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2013-03-19/600513_20130320_4.pdf
297,2013-03-20,联环药业2012年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2013-03-19/600513_20130320_6.pdf
298,2013-03-20,联环药业2012年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2013-03-19/600513_20130320_13.pdf
299,2013-03-20,联环药业2012年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2013-03-19/600513_20130320_9.pdf
300,2013-03-20,联环药业2012年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2013-03-19/600513_20130320_10.pdf
301,2013-03-20,联环药业2012年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2013-03-19/600513_20130320_8.pdf
302,2013-03-20,联环药业2012年度财务报表审计报告,/disclosure/listedinfo/announcement/c/2013-03-19/600513_20130320_12.pdf
303,2013-03-26,联环药业关于召开公司2012年度股东大会的通知,/disclosure/listedinfo/announcement/c/2013-03-25/600513_20130326_1.pdf
304,2013-04-08,联环药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2013-04-07/600513_20130408_1.pdf
305,2013-04-17,联环药业2012年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-04-16/600513_20130417_1.pdf
306,2013-04-23,联环药业2012年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2013-04-22/600513_20130423_2.pdf
307,2013-04-23,联环药业2012年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-04-22/600513_20130423_1.pdf
308,2013-04-25,联环药业总经理工作细则,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_6.pdf
309,2013-04-25,联环药业子公司内部审计实施办法,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_23.pdf
310,2013-04-25,联环药业子公司管理控制制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_21.pdf
311,2013-04-25,联环药业子公司董事、监事、高管委派制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_22.pdf
312,2013-04-25,联环药业重大事项会计处理办法,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_17.pdf
313,2013-04-25,联环药业预算编制管理制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_16.pdf
314,2013-04-25,联环药业无形资产管理制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_14.pdf
315,2013-04-25,联环药业授权管理制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_7.pdf
316,2013-04-25,联环药业企业并购管理制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_13.pdf
317,2013-04-25,联环药业内部信息传递管理制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_9.pdf
318,2013-04-25,联环药业关联交易管理制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_20.pdf
319,2013-04-25,联环药业反舞弊制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_10.pdf
320,2013-04-25,联环药业发展战略管理制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_5.pdf
321,2013-04-25,联环药业对外捐赠管理制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_15.pdf
322,2013-04-25,联环药业第一季度季报,/disclosure/listedinfo/announcement/c/2013-04-24/600513_2013_1.pdf
323,2013-04-25,联环药业第五届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_3.pdf
324,2013-04-25,联环药业筹资执行管理制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_19.pdf
325,2013-04-25,联环药业筹资决策管理制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_18.pdf
326,2013-04-25,联环药业长期股权投资管理制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_11.pdf
327,2013-04-25,联环药业长期股权投资处置管理制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_12.pdf
328,2013-04-25,联环药业“三重一大”集体决策审批制度,/disclosure/listedinfo/announcement/c/2013-04-24/600513_20130425_8.pdf
329,2013-05-08,联环药业关于中国证监会并购重组委审核本公司重大资产重组事项暨公司股票停牌公告,/disclosure/listedinfo/announcement/c/2013-05-07/600513_20130508_1.pdf
330,2013-05-15,联环药业关于重大资产重组项目获得中国证监会并购重组委审核通过暨公司股票复牌公告,/disclosure/listedinfo/announcement/c/2013-05-14/600513_20130515_1.pdf
331,2013-05-27,联环药业2012年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2013-05-26/600513_20130527_1.pdf
332,2013-06-01,联环药业向特定对象发行股份购买资产暨关联交易的补充法律意见书（三）,/disclosure/listedinfo/announcement/c/2013-05-31/600513_20130601_6.pdf
333,2013-06-01,联环药业向特定对象发行股份购买资产暨关联交易的补充法律意见书（二）,/disclosure/listedinfo/announcement/c/2013-05-31/600513_20130601_5.pdf
334,2013-06-01,联环药业关于重大资产重组项目获得中国证监会核准的公告,/disclosure/listedinfo/announcement/c/2013-05-31/600513_20130601_1.pdf
335,2013-06-01,联环药业关于《公司发行股份购买资产暨关联交易报告书》及其摘要中更新内容的说明,/disclosure/listedinfo/announcement/c/2013-05-31/600513_20130601_7.pdf
336,2013-06-01,联环药业发行股份购买资产暨关联交易之独立财务顾问报告,/disclosure/listedinfo/announcement/c/2013-05-31/600513_20130601_4.pdf
337,2013-06-01,联环药业发行股份购买资产暨关联交易报告书摘要,/disclosure/listedinfo/announcement/c/2013-05-31/600513_20130601_3.pdf
338,2013-06-01,联环药业发行股份购买资产暨关联交易报告书,/disclosure/listedinfo/announcement/c/2013-05-31/600513_20130601_2.pdf
339,2013-06-14,联环药业向特定对象发行股份购买资产暨关联交易涉及的标的资产过户事宜的法律意见书,/disclosure/listedinfo/announcement/c/2013-06-13/600513_20130614_3.pdf
340,2013-06-14,联环药业关于发行股份购买资产之标的资产过户完成的公告,/disclosure/listedinfo/announcement/c/2013-06-13/600513_20130614_1.pdf
341,2013-06-14,联环药业发行股份购买资产暨关联交易实施情况之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2013-06-13/600513_20130614_2.pdf
342,2013-06-22,联环药业验资报告,/disclosure/listedinfo/announcement/c/2013-06-21/600513_20130622_4.pdf
343,2013-06-22,联环药业向特定对象发行股份购买资产暨关联交易实施情况的法律意见书,/disclosure/listedinfo/announcement/c/2013-06-21/600513_20130622_3.pdf
344,2013-06-22,联环药业发行股份购买资产暨关联交易实施情况暨股份变动报告书,/disclosure/listedinfo/announcement/c/2013-06-21/600513_20130622_1.pdf
345,2013-06-22,联环药业发行股份购买资产暨关联交易实施情况之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2013-06-21/600513_20130622_2.pdf
346,2013-06-28,联环药业关于发行股份后完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2013-06-27/600513_20130628_1.pdf
347,2013-06-28,联环药业公司章程（2013修订）,/disclosure/listedinfo/announcement/c/2013-06-27/600513_20130628_2.pdf
348,2013-08-23,联环药业独立董事关于关联交易的事前认可函,/disclosure/listedinfo/announcement/c/2013-08-22/600513_20130823_7.pdf
349,2013-08-23,联环药业独立董事关于关联交易的独立意见,/disclosure/listedinfo/announcement/c/2013-08-22/600513_20130823_8.pdf
350,2013-08-23,联环药业第五届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-22/600513_20130823_1.pdf
351,2013-08-23,联环药业半年报摘要,/disclosure/listedinfo/announcement/c/2013-08-22/600513_2013_zzy.pdf
352,2013-08-23,联环药业半年报,/disclosure/listedinfo/announcement/c/2013-08-22/600513_2013_z.pdf
353,2013-08-23,联环药业：综合服务协议,/disclosure/listedinfo/announcement/c/2013-08-22/600513_20130823_5.pdf
354,2013-08-23,联环药业：土地使用权租赁协议,/disclosure/listedinfo/announcement/c/2013-08-22/600513_20130823_4.pdf
355,2013-08-23,联环药业：江苏联环药业集团有限公司与扬州制药有限公司之污水委托处理协议,/disclosure/listedinfo/announcement/c/2013-08-22/600513_20130823_6.pdf
356,2013-08-23,联环药业：房屋租赁协议,/disclosure/listedinfo/announcement/c/2013-08-22/600513_20130823_3.pdf
357,2013-08-27,联环药业半年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2013-08-26/600513_2013_zzy.pdf
358,2013-08-27,联环药业半年报（修订版）,/disclosure/listedinfo/announcement/c/2013-08-26/600513_2013_z.pdf
359,2013-08-27,联环药业2013年半年度报告更正公告,/disclosure/listedinfo/announcement/c/2013-08-26/600513_20130827_2.pdf
360,2013-10-25,联环药业第三季度季报,/disclosure/listedinfo/announcement/c/2013-10-24/600513_2013_3.pdf
361,2013-10-30,联环药业关于召开公司2013年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-10-29/600513_20131030_3.pdf
362,2013-10-30,联环药业对外投资公告,/disclosure/listedinfo/announcement/c/2013-10-29/600513_20131030_2.pdf
363,2013-10-30,联环药业第五届董事会第一次临时会议决议公告,/disclosure/listedinfo/announcement/c/2013-10-29/600513_20131030_1.pdf
364,2013-11-14,联环药业2013年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-11-13/600513_20131114_1.pdf
365,2013-11-19,联环药业2013年第二次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2013-11-18/600513_20131119_2.pdf
366,2013-11-19,联环药业2013年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-11-18/600513_20131119_1.pdf
367,2013-12-19,联环药业关于公司2013年度年报审计机构转制更名的公告,/disclosure/listedinfo/announcement/c/2013-12-18/600513_20131219_1.pdf
368,2014-02-15,联环药业关于实际控制人、股东、关联方、收购人及公司承诺履行情况的公告,/disclosure/listedinfo/announcement/c/2014-02-14/600513_20140215_1.pdf
369,2014-04-25,联环药业预计2014年度日常关联交易的公告,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_5.pdf
370,2014-04-25,联环药业未来三年股东回报规划（2014-2016年）,/disclosure/listedinfo/announcement/c/2014-04-26/600513_20140425_32.pdf
371,2014-04-25,联环药业年报摘要,/disclosure/listedinfo/announcement/c/2014-04-24/600513_2013_nzy.pdf
372,2014-04-25,联环药业年报,/disclosure/listedinfo/announcement/c/2014-04-24/600513_2013_n.pdf
373,2014-04-25,联环药业募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_15.pdf
374,2014-04-25,联环药业募集资金管理办法,/disclosure/listedinfo/announcement/c/2014-04-26/600513_20140425_24.pdf
375,2014-04-25,联环药业关于召开公司2013年度股东大会的通知,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_6.pdf
376,2014-04-25,联环药业关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_3.pdf
377,2014-04-25,联环药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_14.pdf
378,2014-04-25,联环药业关于独立董事辞职的公告,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_7.pdf
379,2014-04-25,联环药业公司组织架构,/disclosure/listedinfo/announcement/c/2014-04-26/600513_20140425_27.pdf
380,2014-04-25,联环药业公司章程（2014修订）,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_20.pdf
381,2014-04-25,联环药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2014-04-26/600513_20140425_26.pdf
382,2014-04-25,联环药业独立董事候选人声明（陈天泉）,/disclosure/listedinfo/announcement/c/2014-04-26/600513_20140425_29.pdf
383,2014-04-25,联环药业独立董事候选人声明（陈玲娣）,/disclosure/listedinfo/announcement/c/2014-04-26/600513_20140425_28.pdf
384,2014-04-25,联环药业独立董事关于预计2014年度日常关联交易事项的事前认可意见,/disclosure/listedinfo/announcement/c/2014-04-26/600513_20140425_33.pdf
385,2014-04-25,联环药业独立董事关于相关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_21.pdf
386,2014-04-25,联环药业董事会提名委员会关于提名公司第五届董事会董事候选人的审核意见,/disclosure/listedinfo/announcement/c/2014-04-26/600513_20140425_31.pdf
387,2014-04-25,联环药业董事会审计委员会工作细则,/disclosure/listedinfo/announcement/c/2014-04-26/600513_20140425_30.pdf
388,2014-04-25,联环药业董事会审计委员会2013年度履职报告,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_18.pdf
389,2014-04-25,联环药业第一季度季报,/disclosure/listedinfo/announcement/c/2014-04-24/600513_2014_1.pdf
390,2014-04-25,联环药业第五届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_4.pdf
391,2014-04-25,联环药业第五届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_2.pdf
392,2014-04-25,联环药业：关于江苏联环药业股份有限公司2013年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_11.pdf
393,2014-04-25,联环药业：房屋租赁协议,/disclosure/listedinfo/announcement/c/2014-04-26/600513_20140425_25.pdf
394,2014-04-25,联环药业2013年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_16.pdf
395,2014-04-25,联环药业2013年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_13.pdf
396,2014-04-25,联环药业2013年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_12.pdf
397,2014-04-25,联环药业2013年度财务报表审计报告,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_10.pdf
398,2014-04-25,联环药业2013年度财务报表审计报告,/disclosure/listedinfo/announcement/c/2014-04-24/600513_20140425_19.pdf
399,2014-04-29,联环药业关于盈利预测实现情况专项审核报告的公告,/disclosure/listedinfo/announcement/c/2014-04-28/600513_20140429_1.pdf
400,2014-04-29,联环药业2013年度业绩承诺完成情况专项审核报告,/disclosure/listedinfo/announcement/c/2014-04-28/600513_20140429_2.pdf
401,2014-05-08,联环药业：光大证券股份有限公司关于江苏联环药业股份有限公司发行股份购买资产暨重大资产重组（关联交易）持续督导工作报告（2013年度）,/disclosure/listedinfo/announcement/c/2014-05-07/600513_20140508_2.pdf
402,2014-05-08,联环药业2013年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-05-07/600513_20140508_1.pdf
403,2014-05-20,联环药业2013年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2014-05-19/600513_20140520_2.pdf
404,2014-05-20,联环药业2013年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-05-19/600513_20140520_1.pdf
405,2014-06-13,联环药业2013年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2014-06-12/600513_20140613_1.pdf
406,2014-07-03,联环药业关于公司重大事项停牌公告,/disclosure/listedinfo/announcement/c/2014-07-02/600513_20140703_1.pdf
407,2014-07-04,联环药业澄清公告,/disclosure/listedinfo/announcement/c/2014-07-03/600513_20140704_1.pdf
408,2014-07-10,联环药业前次募集资金使用情况报告,/disclosure/listedinfo/announcement/c/2014-07-09/600513_20140710_6.pdf
409,2014-07-10,联环药业关于非公开发行股票募集资金运用可行性分析报告,/disclosure/listedinfo/announcement/c/2014-07-09/600513_20140710_5.pdf
410,2014-07-10,联环药业复牌提示性公告,/disclosure/listedinfo/announcement/c/2014-07-09/600513_20140710_3.pdf
411,2014-07-10,联环药业非公开发行股票预案,/disclosure/listedinfo/announcement/c/2014-07-09/600513_20140710_2.pdf
412,2014-07-10,联环药业第五届董事会第二次临时会议决议公告,/disclosure/listedinfo/announcement/c/2014-07-09/600513_20140710_1.pdf
413,2014-07-10,联环药业：关于公司前次募集资金使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2014-07-09/600513_20140710_4.pdf
414,2014-07-25,联环药业第五届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2014-07-24/600513_20140725_3.pdf
415,2014-07-25,联环药业半年报摘要,/disclosure/listedinfo/announcement/c/2014-07-24/600513_2014_zzy.pdf
416,2014-07-25,联环药业半年报,/disclosure/listedinfo/announcement/c/2014-07-24/600513_2014_z.pdf
417,2014-07-25,联环药业2014年1-6月财务报表审计报告,/disclosure/listedinfo/announcement/c/2014-07-24/600513_20140725_5.pdf
418,2014-08-02,联环药业关于增加经营范围暨修改《公司章程》的公告,/disclosure/listedinfo/announcement/c/2014-08-01/600513_20140802_2.pdf
419,2014-08-02,联环药业公司章程（2014修订）,/disclosure/listedinfo/announcement/c/2014-08-01/600513_20140802_4.pdf
420,2014-08-02,联环药业第五届董事会第三次临时会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-01/600513_20140802_1.pdf
421,2014-08-02,联环药业：合同解除协议,/disclosure/listedinfo/announcement/c/2014-08-01/600513_20140802_3.pdf
422,2014-08-05,联环药业关于非公开发行股票有关事宜获得江苏省国资委批复的公告,/disclosure/listedinfo/announcement/c/2014-08-04/600513_20140805_1.pdf
423,2014-08-22,联环药业关于召开公司2014年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-08-21/600513_20140822_1.pdf
424,2014-08-22,联环药业2014年第一次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2014-08-21/600513_20140822_2.pdf
425,2014-09-11,联环药业2014年第一次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2014-09-10/600513_20140911_2.pdf
426,2014-09-11,联环药业2014年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-09-10/600513_20140911_1.pdf
427,2014-10-16,联环药业关于中国证监会受理公司非公开发行股票申请的公告,/disclosure/listedinfo/announcement/c/2014-10-15/600513_20141016_1.pdf
428,2014-10-29,联环药业第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-28/600513_2014_3.pdf
429,2014-11-07,联环药业关于独立董事辞职的公告,/disclosure/listedinfo/announcement/c/2014-11-06/600513_20141107_1.pdf
430,2014-12-09,联环药业关于最近五年被证券监管部门和交易所采取处罚或监管措施及整改情况的公告,/disclosure/listedinfo/announcement/c/2014-12-08/600513_20141209_2.pdf
431,2014-12-09,联环药业关于本次非公开发行股票摊薄即期回报的风险提示及公司采取措施的公告,/disclosure/listedinfo/announcement/c/2014-12-08/600513_20141209_1.pdf
432,2015-01-01,联环药业关于本次拟募集资金投资年产20000kg地塞米松磷酸钠原料药建设项目与原有产能、效益有效区分的公告,/disclosure/listedinfo/announcement/c/2014-12-31/600513_20150101_1.pdf
433,2015-01-28,联环药业预计2015年度日常关联交易的公告,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_5.pdf
434,2015-01-28,联环药业投资者关系管理制度,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_24.pdf
435,2015-01-28,联环药业年报摘要,/disclosure/listedinfo/announcement/c/2015-01-27/600513_2014_nzy.pdf
436,2015-01-28,联环药业年报,/disclosure/listedinfo/announcement/c/2015-01-27/600513_2014_n.pdf
437,2015-01-28,联环药业内部控制评价管理办法,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_22.pdf
438,2015-01-28,联环药业累积投票制实施细则,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_21.pdf
439,2015-01-28,联环药业关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_6.pdf
440,2015-01-28,联环药业关于修订《公司章程》及其附件《股东大会议事规则》的公告,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_4.pdf
441,2015-01-28,联环药业公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_25.pdf
442,2015-01-28,联环药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_16.pdf
443,2015-01-28,联环药业独立董事候选人声明（周建平）,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_19.pdf
444,2015-01-28,联环药业独立董事候选人声明（侯维平）,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_18.pdf
445,2015-01-28,联环药业独立董事候选人声明（陈玲娣）,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_17.pdf
446,2015-01-28,联环药业独立董事关于相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_26.pdf
447,2015-01-28,联环药业独立董事关于关联交易事项的事前认可意见,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_20.pdf
448,2015-01-28,联环药业董事会提名委员会关于提名公司第六届董事会董事候选人的审核意见,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_23.pdf
449,2015-01-28,联环药业董事会审计委员会2014年度履职报告,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_14.pdf
450,2015-01-28,联环药业董监高持有本公司股份及其变动管理办法,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_15.pdf
451,2015-01-28,联环药业第五届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_3.pdf
452,2015-01-28,联环药业第五届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_28.pdf
453,2015-01-28,联环药业：关于扬州制药有限公司2014年度盈利预测实现情况的专项审核报告,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_12.pdf
454,2015-01-28,联环药业：关于江苏联环药业股份有限公司2014年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_9.pdf
455,2015-01-28,联环药业2014年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_13.pdf
456,2015-01-28,联环药业2014年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_11.pdf
457,2015-01-28,联环药业2014年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_10.pdf
458,2015-01-28,联环药业2014年度财务报表审计报告,/disclosure/listedinfo/announcement/c/2015-01-27/600513_20150128_8.pdf
459,2015-01-29,联环药业关于重新审议关联交易的公告,/disclosure/listedinfo/announcement/c/2015-01-28/600513_20150129_3.pdf
460,2015-01-29,联环药业关于第五届董事会第十三次会议决议的更正公告,/disclosure/listedinfo/announcement/c/2015-01-28/600513_20150129_1.pdf
461,2015-01-29,联环药业关于2014年年度股东大会的更正公告,/disclosure/listedinfo/announcement/c/2015-01-28/600513_20150129_2.pdf
462,2015-01-29,联环药业独立董事关于相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-01-28/600513_20150129_4.pdf
463,2015-02-13,联环药业：光大证券股份有限公司关于江苏联环药业股份有限公司发行股份购买资产暨重大资产重组（关联交易）持续督导报告（2014年度）,/disclosure/listedinfo/announcement/c/2015-02-12/600513_20150213_1.pdf
464,2015-03-03,联环药业关于公司非公开发行股票事项获得中国证监会发审委审核通过的公告,/disclosure/listedinfo/announcement/c/2015-03-02/600513_20150303_1.pdf
465,2015-03-10,联环药业2014年年度股东大会会议材料,/disclosure/listedinfo/announcement/c/2015-03-09/600513_20150310_1.pdf
466,2015-03-11,联环药业年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2015-03-10/600513_2014_nzy.pdf
467,2015-03-11,联环药业年报（修订版）,/disclosure/listedinfo/announcement/c/2015-03-10/600513_2014_n.pdf
468,2015-03-11,联环药业关于2014年年报事后审核意见回复的公告,/disclosure/listedinfo/announcement/c/2015-03-10/600513_20150311_1.pdf
469,2015-03-19,联环药业关于职工代表监事换届选举的公告,/disclosure/listedinfo/announcement/c/2015-03-18/600513_20150319_2.pdf
470,2015-03-19,联环药业2014年年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2015-03-18/600513_20150319_3.pdf
471,2015-03-19,联环药业2014年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-03-18/600513_20150319_1.pdf
472,2015-03-27,联环药业2014年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2015-03-26/600513_20150327_1.pdf
473,2015-03-31,联环药业独立董事关于聘任公司高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2015-03-30/600513_20150331_3.pdf
474,2015-03-31,联环药业第六届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-30/600513_20150331_2.pdf
475,2015-03-31,联环药业第六届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-30/600513_20150331_1.pdf
476,2015-04-08,联环药业关于实施2014年度利润分配预案后调整非公开发行股票发行底价的公告,/disclosure/listedinfo/announcement/c/2015-04-07/600513_20150408_2.pdf
477,2015-04-08,联环药业关于非公开发行股票获得中国证券监督管理委员会核准批复的公告,/disclosure/listedinfo/announcement/c/2015-04-07/600513_20150408_1.pdf
478,2015-04-25,联环药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-04-24/600513_20150425_3.pdf
479,2015-04-25,联环药业第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-24/600513_2015_1.pdf
480,2015-04-30,联环药业非公开发行股票发行情况报告书,/disclosure/listedinfo/announcement/c/2015-04-29/600513_20150430_4.pdf
481,2015-04-30,联环药业非公开发行股票发行结果暨股本变动公告,/disclosure/listedinfo/announcement/c/2015-04-29/600513_20150430_1.pdf
482,2015-04-30,联环药业：验资报告,/disclosure/listedinfo/announcement/c/2015-04-29/600513_20150430_2.pdf
483,2015-04-30,联环药业：光大证券股份有限公司关于江苏联环药业股份有限公司非公开发行股票之上市保荐书,/disclosure/listedinfo/announcement/c/2015-04-29/600513_20150430_6.pdf
484,2015-04-30,联环药业：光大证券股份有限公司关于江苏联环药业股份有限公司非公开发行股票发行过程和认购对象合规性的报告,/disclosure/listedinfo/announcement/c/2015-04-29/600513_20150430_5.pdf
485,2015-04-30,联环药业：北京市竞天公诚律师事务所关于江苏联环药业股份有限公司非公开发行人民币普通股股票发行过程及认购对象合规性的法律意见书,/disclosure/listedinfo/announcement/c/2015-04-29/600513_20150430_3.pdf
486,2015-05-06,联环药业关于签订募集资金三方监管协议的公告,/disclosure/listedinfo/announcement/c/2015-05-05/600513_20150506_1.pdf
487,2015-05-13,联环药业关于修改《公司章程》的公告,/disclosure/listedinfo/announcement/c/2015-05-12/600513_20150513_4.pdf
488,2015-05-13,联环药业关于使用募集资金置换预先已投入募投项目的自筹资金的公告,/disclosure/listedinfo/announcement/c/2015-05-12/600513_20150513_2.pdf
489,2015-05-13,联环药业公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-05-12/600513_20150513_8.pdf
490,2015-05-13,联环药业独立董事关于以募集资金置换已预先投入募投项目自筹资金的独立意见,/disclosure/listedinfo/announcement/c/2015-05-12/600513_20150513_5.pdf
491,2015-05-13,联环药业第六届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2015-05-12/600513_20150513_3.pdf
492,2015-05-13,联环药业第六届董事会第一次临时会议决议公告,/disclosure/listedinfo/announcement/c/2015-05-12/600513_20150513_1.pdf
493,2015-05-13,联环药业：光大证券股份有限公司关于江苏联环药业股份有限公司使用募集资金置换预先投入募集资金投资项目自筹资金事项之核查意见,/disclosure/listedinfo/announcement/c/2015-05-12/600513_20150513_6.pdf
494,2015-05-13,联环药业：关于江苏联环药业股份有限公司以募集资金置换已投入募集资金项目的自筹资金的审核报告,/disclosure/listedinfo/announcement/c/2015-05-12/600513_20150513_7.pdf
495,2015-05-27,联环药业关于签订募集资金四方监管协议的公告,/disclosure/listedinfo/announcement/c/2015-05-26/600513_20150527_1.pdf
496,2015-07-07,联环药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-07-06/600513_20150707_1.pdf
497,2015-07-10,联环药业关于控股股东承诺不减持并拟增持公司股票的公告,/disclosure/listedinfo/announcement/c/2015-07-09/600513_20150710_1.pdf
498,2015-07-15,联环药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-07-14/600513_20150715_1.pdf
499,2015-08-28,联环药业关于控股股东增持公司股份的公告,/disclosure/listedinfo/announcement/c/2015-08-28/600513_20150828_5.pdf
500,2015-08-28,联环药业对外投资公告,/disclosure/listedinfo/announcement/c/2015-08-28/600513_20150828_4.pdf
501,2015-08-28,联环药业独立董事关于公司2015年上半年募集资金存放与实际使用情况的独立意见,/disclosure/listedinfo/announcement/c/2015-08-28/600513_20150828_8.pdf
502,2015-08-28,联环药业董事会秘书工作制度,/disclosure/listedinfo/announcement/c/2015-08-28/600513_20150828_9.pdf
503,2015-08-28,联环药业第六届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-28/600513_20150828_6.pdf
504,2015-08-28,联环药业第六届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-28/600513_20150828_1.pdf
505,2015-08-28,联环药业半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-28/600513_2015_zzy.pdf
506,2015-08-28,联环药业半年报,/disclosure/listedinfo/announcement/c/2015-08-28/600513_2015_z.pdf
507,2015-08-28,联环药业2015年上半年募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2015-08-28/600513_20150828_3.pdf
508,2015-09-03,联环药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-09-03/600513_20150903_1.pdf
509,2015-10-29,联环药业关于更换保荐代表人的公告,/disclosure/listedinfo/announcement/c/2015-10-29/600513_20151029_3.pdf
510,2015-10-29,联环药业第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-29/600513_2015_3.pdf
511,2015-10-29,联环药业第六届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-10-29/600513_20151029_2.pdf
512,2015-12-07,联环药业关于撤回复方非洛地平缓释片及草酸依地普伦片申报生产申请的公告,/disclosure/listedinfo/announcement/c/2015-12-07/600513_20151207_1.pdf
513,2016-01-11,联环药业关于获得阿齐沙坦片临床批件的公告,/disclosure/listedinfo/announcement/c/2016-01-11/600513_20160111_1.pdf
514,2016-01-12,联环药业关于获得阿齐沙坦片临床批件的补充公告,/disclosure/listedinfo/announcement/c/2016-01-12/600513_20160112_1.pdf
515,2016-03-26,联环药业关于更换职工代表监事的公告,/disclosure/listedinfo/announcement/c/2016-03-26/600513_20160326_1.pdf
516,2016-04-22,联环药业预计2016年度日常关联交易的公告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_6.pdf
517,2016-04-22,联环药业募集资金2015年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_18.pdf
518,2016-04-22,联环药业关于重新审议关联交易的公告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_5.pdf
519,2016-04-22,联环药业关于召开2015年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_8.pdf
520,2016-04-22,联环药业关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_4.pdf
521,2016-04-22,联环药业关于募集资金2015年度存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_17.pdf
522,2016-04-22,联环药业关于募集资金2015年度存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_7.pdf
523,2016-04-22,联环药业关于独立董事辞职的公告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_9.pdf
524,2016-04-22,联环药业关于董事辞职的公告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_10.pdf
525,2016-04-22,联环药业公司章程（2016修订),/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_29.pdf
526,2016-04-22,联环药业对外投资管理制度,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_28.pdf
527,2016-04-22,联环药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_25.pdf
528,2016-04-22,联环药业独立董事候选人声明（张雷）,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_26.pdf
529,2016-04-22,联环药业独立董事关于相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_30.pdf
530,2016-04-22,联环药业独立董事关于关联交易事项的事前认可意见,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_24.pdf
531,2016-04-22,联环药业董事会提名委员会关于提名公司董事候选人的审核意见,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_27.pdf
532,2016-04-22,联环药业董事会审计委员会2015年度履职报告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_22.pdf
533,2016-04-22,联环药业第六届监事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_3.pdf
534,2016-04-22,联环药业第六届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_2.pdf
535,2016-04-22,联环药业：光大证券股份有限公司关于江苏联环药业股份有限公司2015年度募集资金存放与使用情况之专项核查报告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_21.pdf
536,2016-04-22,联环药业：光大证券股份有限公司关于江苏联环药业股份有限公司2015年度持续督导年度报告书,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_23.pdf
537,2016-04-22,联环药业：关于扬州制药有限公司2015年度盈利预测实现情况的专项审核报告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_19.pdf
538,2016-04-22,联环药业：关于江苏联环药业股份有限公司2015年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_14.pdf
539,2016-04-22,联环药业2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_2016_1.pdf
540,2016-04-22,联环药业2015年年度报告摘要,/disclosure/listedinfo/announcement/c/2016-04-22/600513_2015_nzy.pdf
541,2016-04-22,联环药业2015年年度报告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_2015_n.pdf
542,2016-04-22,联环药业2015年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_20.pdf
543,2016-04-22,联环药业2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_16.pdf
544,2016-04-22,联环药业2015年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_15.pdf
545,2016-04-22,联环药业2015年度财务报表审计报告,/disclosure/listedinfo/announcement/c/2016-04-22/600513_20160422_13.pdf
546,2016-04-23,联环药业关于获得硫酸氢氯吡格雷的原料药注册批件及其片剂临床批件的公告,/disclosure/listedinfo/announcement/c/2016-04-23/600513_20160423_1.pdf
547,2016-04-26,联环药业非公开发行限售股上市流通公告,/disclosure/listedinfo/announcement/c/2016-04-26/600513_20160426_1.pdf
548,2016-04-26,联环药业：光大证券股份有限公司关于江苏联环药业股份有限公司限售股份上市流通的核查意见,/disclosure/listedinfo/announcement/c/2016-04-26/600513_20160426_2.pdf
549,2016-05-06,联环药业关于召开2015年度业绩说明会的预告公告,/disclosure/listedinfo/announcement/c/2016-05-06/600513_20160506_1.pdf
550,2016-05-11,联环药业2015年年度股东大会会议材料,/disclosure/listedinfo/announcement/c/2016-05-11/600513_20160511_1.pdf
551,2016-05-13,联环药业资产处置公告,/disclosure/listedinfo/announcement/c/2016-05-13/600513_20160513_2.pdf
552,2016-05-13,联环药业关于撤回苯磺贝他斯汀片申报生产申请的公告,/disclosure/listedinfo/announcement/c/2016-05-13/600513_20160513_3.pdf
553,2016-05-13,联环药业第六届董事会第二次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-05-13/600513_20160513_1.pdf
554,2016-05-13,联环药业拆迁补偿涉及的部分资产项目评估报告,/disclosure/listedinfo/announcement/c/2016-05-13/600513_20160513_4.pdf
555,2016-05-17,联环药业关于资产处置的补充公告,/disclosure/listedinfo/announcement/c/2016-05-17/600513_20160517_1.pdf
556,2016-05-19,联环药业2015年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-05-19/600513_20160519_1.pdf
557,2016-05-19,联环药业2015年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-05-19/600513_20160519_2.pdf
558,2016-06-01,联环药业第六届董事会第三次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-06-01/600513_20160601_1.pdf
559,2016-06-02,联环药业关于收到搬迁补偿款的公告,/disclosure/listedinfo/announcement/c/2016-06-02/600513_20160602_1.pdf
560,2016-06-16,联环药业重大资产重组限售股上市流通公告,/disclosure/listedinfo/announcement/c/2016-06-16/600513_20160616_1.pdf
561,2016-06-16,联环药业：光大证券股份有限公司关于江苏联环药业股份有限公司发行股份购买资产限售股份上市流通的核查意见,/disclosure/listedinfo/announcement/c/2016-06-16/600513_20160616_2.pdf
562,2016-06-28,联环药业关于全资子公司扬州制药有限公司氢化可的松等原料药生产线通过FDA认证的公告,/disclosure/listedinfo/announcement/c/2016-06-28/600513_20160628_1.pdf
563,2016-06-30,联环药业关于2015年度利润分配及转增股本实施公告,/disclosure/listedinfo/announcement/c/2016-06-30/600513_20160630_1.pdf
564,2016-07-09,联环药业章程（2016修订）,/disclosure/listedinfo/announcement/c/2016-07-09/600513_20160709_5.pdf
565,2016-07-09,联环药业关于召开2016年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-07-09/600513_20160709_4.pdf
566,2016-07-09,联环药业关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2016-07-09/600513_20160709_3.pdf
567,2016-07-09,联环药业第六届董事会第四次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-07-09/600513_20160709_2.pdf
568,2016-07-09,联环药业2016年第一次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2016-07-09/600513_20160709_1.pdf
569,2016-07-27,联环药业2016年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-07-27/600513_20160727_1.pdf
570,2016-07-27,联环药业2016年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-07-27/600513_20160727_2.pdf
571,2016-08-23,联环药业关于更换保荐代表人的公告,/disclosure/listedinfo/announcement/c/2016-08-23/600513_20160823_1.pdf
572,2016-08-25,联环药业投资者投诉处理工作制度,/disclosure/listedinfo/announcement/c/2016-08-25/600513_20160825_8.pdf
573,2016-08-25,联环药业关于重新审议关联交易的公告,/disclosure/listedinfo/announcement/c/2016-08-25/600513_20160825_5.pdf
574,2016-08-25,联环药业关联交易管理制度,/disclosure/listedinfo/announcement/c/2016-08-25/600513_20160825_7.pdf
575,2016-08-25,联环药业独立董事关于相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-08-25/600513_20160825_10.pdf
576,2016-08-25,联环药业独立董事关于关联交易事项的事前认可意见,/disclosure/listedinfo/announcement/c/2016-08-25/600513_20160825_9.pdf
577,2016-08-25,联环药业第六届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-25/600513_20160825_3.pdf
578,2016-08-25,联环药业第六届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-25/600513_20160825_2.pdf
579,2016-08-25,联环药业：扬州制药有限公司与扬州联澳生物医药有限公司之原料药采购协议,/disclosure/listedinfo/announcement/c/2016-08-25/600513_20160825_15.pdf
580,2016-08-25,联环药业：联环集团与扬州制药综合服务协议,/disclosure/listedinfo/announcement/c/2016-08-25/600513_20160825_14.pdf
581,2016-08-25,联环药业：联环集团与扬州制药土地使用权租赁协议,/disclosure/listedinfo/announcement/c/2016-08-25/600513_20160825_12.pdf
582,2016-08-25,联环药业：联环集团与扬州制药房屋租赁协议,/disclosure/listedinfo/announcement/c/2016-08-25/600513_20160825_11.pdf
583,2016-08-25,联环药业：江苏联环药业集团有限公司与扬州制药有限公司之污水委托处理协议,/disclosure/listedinfo/announcement/c/2016-08-25/600513_20160825_13.pdf
584,2016-08-25,联环药业2016年上半年募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-08-25/600513_20160825_4.pdf
585,2016-08-25,联环药业2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-25/600513_2016_zzy.pdf
586,2016-08-25,联环药业2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-25/600513_2016_z.pdf
587,2016-09-22,联环药业关于2016年半年度报告修订说明的公告,/disclosure/listedinfo/announcement/c/2016-09-22/600513_20160922_1.pdf
588,2016-09-22,联环药业2016年半年度报告（修订版）,/disclosure/listedinfo/announcement/c/2016-09-22/600513_2016_z.pdf
589,2016-10-28,联环药业2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-28/600513_2016_3.pdf
590,2016-11-29,联环药业独立董事关于放弃优先购买权的独立意见,/disclosure/listedinfo/announcement/c/2016-11-29/600513_20161129_4.pdf
591,2016-11-29,联环药业第六届董事会第五次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-11-29/600513_20161129_1.pdf
592,2016-11-29,联环药业：股权转让框架协议,/disclosure/listedinfo/announcement/c/2016-11-29/600513_20161129_2.pdf
593,2016-11-29,联环药业：股东放弃股权优先购买权声明,/disclosure/listedinfo/announcement/c/2016-11-29/600513_20161129_3.pdf
594,2016-12-01,联环药业关于获得安奈格列汀原料药审批意见通知件及其片剂临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-12-01/600513_20161201_1.pdf
595,2016-12-22,联环药业关于完成控股子公司注销登记的公告,/disclosure/listedinfo/announcement/c/2016-12-22/600513_20161222_1.pdf
596,2016-12-29,联环药业关于总经理辞职的公告,/disclosure/listedinfo/announcement/c/2016-12-29/600513_20161229_3.pdf
597,2016-12-29,联环药业关于召开2017年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-12-29/600513_20161229_5.pdf
598,2016-12-29,联环药业关于修订《公司章程》及其附件《股东大会议事规则》《董事会议事规则》的公告,/disclosure/listedinfo/announcement/c/2016-12-29/600513_20161229_4.pdf
599,2016-12-29,联环药业公司章程（2016修订）,/disclosure/listedinfo/announcement/c/2016-12-29/600513_20161229_8.pdf
600,2016-12-29,联环药业独立董事关于董事候选人的独立意见,/disclosure/listedinfo/announcement/c/2016-12-29/600513_20161229_6.pdf
601,2016-12-29,联环药业董事会提名委员会关于提名公司董事候选人的审核意见,/disclosure/listedinfo/announcement/c/2016-12-29/600513_20161229_7.pdf
602,2016-12-29,联环药业董事长辞职公告,/disclosure/listedinfo/announcement/c/2016-12-29/600513_20161229_2.pdf
603,2016-12-29,联环药业第六届董事会第六次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-12-29/600513_20161229_1.pdf
604,2017-01-17,联环药业2017年第一次临时股东大会会议材料,/disclosure/listedinfo/announcement/c/2017-01-17/600513_20170117_1.pdf
605,2017-01-24,联环药业2017年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-01-24/600513_20170124_1.pdf
606,2017-01-24,联环药业2017年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-01-24/600513_20170124_2.pdf
607,2017-02-18,联环药业拟转让持有扬州联澳生物医药有限公司40%股权涉及公司股东部分权益评估报告,/disclosure/listedinfo/announcement/c/2017-02-18/600513_20170218_3.pdf
608,2017-02-18,联环药业关于挂牌转让扬州联澳生物医药有限公司40%股权的公告,/disclosure/listedinfo/announcement/c/2017-02-18/600513_20170218_2.pdf
609,2017-02-18,联环药业独立董事独立意见,/disclosure/listedinfo/announcement/c/2017-02-18/600513_20170218_5.pdf
610,2017-02-18,联环药业第六届董事会第七次临时会议决议公告,/disclosure/listedinfo/announcement/c/2017-02-18/600513_20170218_1.pdf
611,2017-02-18,联环药业：扬州联澳生物医药有限公司审计报告,/disclosure/listedinfo/announcement/c/2017-02-18/600513_20170218_4.pdf
612,2017-03-17,联环药业预计2017年度日常关联交易的公告,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_6.pdf
613,2017-03-17,联环药业关于证券事务代表辞职的公告,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_5.pdf
614,2017-03-17,联环药业关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_7.pdf
615,2017-03-17,联环药业独立董事关于预计2017年度日常关联交易的事前认可意见,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_18.pdf
616,2017-03-17,联环药业独立董事关于相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_8.pdf
617,2017-03-17,联环药业董事会审计委员会2016年度履职报告,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_16.pdf
618,2017-03-17,联环药业第六届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_3.pdf
619,2017-03-17,联环药业第六届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_28.pdf
620,2017-03-17,联环药业：组织架构图,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_17.pdf
621,2017-03-17,联环药业：募集资金2016年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_13.pdf
622,2017-03-17,联环药业：光大证券股份有限公司关于江苏联环药业股份有限公司2016年度募集资金存放与使用情况之专项核查报告,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_15.pdf
623,2017-03-17,联环药业：关于江苏联环药业股份有限公司2016年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_10.pdf
624,2017-03-17,联环药业：2016年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_14.pdf
625,2017-03-17,联环药业：2016年度财务报表审计报告,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_9.pdf
626,2017-03-17,联环药业2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-03-17/600513_2016_nzy.pdf
627,2017-03-17,联环药业2016年年度报告,/disclosure/listedinfo/announcement/c/2017-03-17/600513_2016_n.pdf
628,2017-03-17,联环药业2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_12.pdf
629,2017-03-17,联环药业2016年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_4.pdf
630,2017-03-17,联环药业2016年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2017-03-17/600513_20170317_11.pdf
631,2017-03-25,联环药业拟进行股权收购涉及的扬州联环医药营销有限公司6.5%股权价值评估报告,/disclosure/listedinfo/announcement/c/2017-03-25/600513_20170325_6.pdf
632,2017-03-25,联环药业拟进行股权收购涉及的南京帝易医药科技有限公司12%股权价值评估报告,/disclosure/listedinfo/announcement/c/2017-03-25/600513_20170325_4.pdf
633,2017-03-25,联环药业关于收购控股子公司扬州联环医药营销有限公司少数股东股权暨关联交易的公告,/disclosure/listedinfo/announcement/c/2017-03-25/600513_20170325_2.pdf
634,2017-03-25,联环药业关于收购控股子公司南京帝易医药科技有限公司少数股东股权的公告,/disclosure/listedinfo/announcement/c/2017-03-25/600513_20170325_3.pdf
635,2017-03-25,联环药业独立董事关于公司收购控股子公司少数股东股权暨关联交易的事前认可意见,/disclosure/listedinfo/announcement/c/2017-03-25/600513_20170325_8.pdf
636,2017-03-25,联环药业独立董事关于公司收购控股子公司少数股东股权暨关联交易的独立意见,/disclosure/listedinfo/announcement/c/2017-03-25/600513_20170325_9.pdf
637,2017-03-25,联环药业第六届董事会第八次临时会议决议公告,/disclosure/listedinfo/announcement/c/2017-03-25/600513_20170325_1.pdf
638,2017-03-25,联环药业：与南京帝易陈睿股权转让协议,/disclosure/listedinfo/announcement/c/2017-03-25/600513_20170325_14.pdf
639,2017-03-25,联环药业：与联环营销于同福股权转让协议,/disclosure/listedinfo/announcement/c/2017-03-25/600513_20170325_11.pdf
640,2017-03-25,联环药业：与联环营销钱望霓股权转让协议,/disclosure/listedinfo/announcement/c/2017-03-25/600513_20170325_10.pdf
641,2017-03-25,联环药业：与联环营销符顺佑股权转让协议,/disclosure/listedinfo/announcement/c/2017-03-25/600513_20170325_13.pdf
642,2017-03-25,联环药业：与联环营销程麒股权转让协议,/disclosure/listedinfo/announcement/c/2017-03-25/600513_20170325_12.pdf
643,2017-03-25,联环药业：扬州联环医药营销有限公司2016年度财务报表审计报告,/disclosure/listedinfo/announcement/c/2017-03-25/600513_20170325_7.pdf
644,2017-03-25,联环药业：南京帝易医药科技有限公司财务报表审计报告,/disclosure/listedinfo/announcement/c/2017-03-25/600513_20170325_5.pdf
645,2017-03-30,联环药业关于收到《光大证券股份有限公司关于江苏联环药业股份有限公司2015年度非公开发行股票之保荐总结报告书》和《光大证券股份有限公司关于江苏联环药业股份有限公司2016年度持续督导年度报告书》的提示性公告,/disclosure/listedinfo/announcement/c/2017-03-30/600513_20170330_1.pdf
646,2017-03-30,联环药业：光大证券股份有限公司关于江苏联环药业股份有限公司2016年度持续督导年度报告书,/disclosure/listedinfo/announcement/c/2017-03-30/600513_20170330_3.pdf
647,2017-03-30,联环药业：光大证券股份有限公司关于江苏联环药业股份有限公司2015年度非公开发行股票之保荐总结报告书,/disclosure/listedinfo/announcement/c/2017-03-30/600513_20170330_2.pdf
648,2017-04-01,联环药业2016年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-04-01/600513_20170401_1.pdf
649,2017-04-07,联环药业关于收购控股子公司扬州联环医药营销有限公司少数股东股权暨关联交易的补充公告,/disclosure/listedinfo/announcement/c/2017-04-07/600513_20170407_1.pdf
650,2017-04-13,联环药业2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-04-13/600513_20170413_1.pdf
651,2017-04-13,联环药业2016年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-04-13/600513_20170413_2.pdf
652,2017-04-20,联环药业2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-20/600513_2017_1.pdf
653,2017-04-26,联环药业关于挂牌转让扬州联澳生物医药有限公司40%股权的进展公告,/disclosure/listedinfo/announcement/c/2017-04-26/600513_20170426_1.pdf
654,2017-05-05,联环药业关于挂牌转让扬州联澳生物医药有限公司40%股权完成的公告,/disclosure/listedinfo/announcement/c/2017-05-05/600513_20170505_1.pdf
655,2017-05-12,联环药业2016年年度权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-05-12/600513_20170512_1.pdf
656,2017-05-27,联环药业关于召开2017年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-05-27/600513_20170527_4.pdf
657,2017-05-27,联环药业关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2017-05-27/600513_20170527_2.pdf
658,2017-05-27,联环药业公司章程（2017年修订）,/disclosure/listedinfo/announcement/c/2017-05-27/600513_20170527_3.pdf
659,2017-05-27,联环药业第六届董事会第九次临时会议决议公告,/disclosure/listedinfo/announcement/c/2017-05-27/600513_20170527_1.pdf
660,2017-06-09,联环药业2017年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-06-09/600513_20170609_1.pdf
661,2017-06-16,联环药业2017年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-06-16/600513_20170616_1.pdf
662,2017-06-16,联环药业2017年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-06-16/600513_20170616_2.pdf
663,2017-08-25,联环药业独立董事关于相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-08-25/600513_20170825_3.pdf
664,2017-08-25,联环药业第六届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-25/600513_20170825_5.pdf
665,2017-08-25,联环药业第六届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-25/600513_20170825_4.pdf
666,2017-08-25,联环药业2017年上半年募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-08-25/600513_20170825_6.pdf
667,2017-08-25,联环药业2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-25/600513_2017_zzy.pdf
668,2017-08-25,联环药业2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-25/600513_2017_z.pdf
669,2017-10-28,联环药业第六届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-28/600513_20171028_3.pdf
670,2017-10-28,联环药业2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-28/600513_2017_3.pdf
671,2017-11-22,联环药业关于对控股子公司进行增资的公告,/disclosure/listedinfo/announcement/c/2017-11-22/600513_20171122_1.pdf
672,2017-12-29,联环药业关于重新审议关联交易的公告,/disclosure/listedinfo/announcement/c/2017-12-29/600513_20171229_2.pdf
673,2017-12-29,联环药业关于召开2018年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-12-29/600513_20171229_8.pdf
674,2017-12-29,联环药业关于监事会主席辞职的公告,/disclosure/listedinfo/announcement/c/2017-12-29/600513_20171229_6.pdf
675,2017-12-29,联环药业关于公司董事、副董事长辞职的公告,/disclosure/listedinfo/announcement/c/2017-12-29/600513_20171229_5.pdf
676,2017-12-29,联环药业关于对外投资设立全资子公司的公告,/disclosure/listedinfo/announcement/c/2017-12-29/600513_20171229_4.pdf
677,2017-12-29,联环药业独立董事关于第六届董事会第十次临时会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-12-29/600513_20171229_3.pdf
678,2017-12-29,联环药业第六届监事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-29/600513_20171229_7.pdf
679,2017-12-29,联环药业第六届董事会第十次临时会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-29/600513_20171229_1.pdf
680,2018-01-10,联环药业关于收到搬迁补偿款的公告,/disclosure/listedinfo/announcement/c/2018-01-10/600513_20180110_1.pdf
681,2018-01-12,联环药业2018年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2018-01-12/600513_20180112_1.pdf
682,2018-01-20,联环药业第六届监事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2018-01-20/600513_20180120_3.pdf
683,2018-01-20,联环药业2018年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2018-01-20/600513_20180120_1.pdf
684,2018-01-20,联环药业2018年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2018-01-20/600513_20180120_2.pdf
